Masayuki Ikeda

An Evaluation of Foreign Clinical Data in the Approval Reviews of Antimicrobial Medicines in Japan: Considering Ethnic and Regional Differences in Data Extrapolations in Accordance With Regulatory Circumstances.

Journal: Pharmacology research & perspectives

Published: March 10, 2026

Real-World Outcomes of Patients With Non-Valvular Atrial Fibrillation on Anticoagulants Ineligible for Phase III Trials of Direct Oral Anticoagulants　- A Retrospective Cohort Study.

Journal: Circulation reports

Published: May 20, 2025

Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data.

Journal: British journal of clinical pharmacology

Published: March 11, 2025

Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study.

Journal: BMJ open diabetes research & care

Published: November 22, 2021

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).

Journal: Journal of pharmaceutical policy and practice

Published: May 09, 2021

Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: A tripartite comparison.

Journal: British journal of clinical pharmacology

Published: September 01, 2020

Comparative examination of levodopa pharmacokinetics during simultaneous administration with lactoferrin in healthy subjects and the relationship between lipids and COMT inhibitory activity in vitro.

Journal: Nutritional neuroscience

Published: May 23, 2020

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.

Journal: Expert review of molecular diagnostics

Published: February 18, 2020

Comparative study on the activities of part-time occupational physicians in Japan between 2008 and 2016: effects of the stress-check program.

Journal: Industrial health

Published: November 01, 2019

Biological monitoring of occupational exposure to dichloromethane by means of urinalysis for un-metabolized dichloromethane.

Journal: Industrial health

Published: April 19, 2019

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.

Journal: Journal of pharmaceutical policy and practice

Published: January 25, 2019

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus.

Journal: Journal of general and family medicine

Published: January 15, 2019

An Evaluation of Foreign Clinical Data in the Approval Reviews of Antimicrobial Medicines in Japan: Considering Ethnic and Regional Differences in Data Extrapolations in Accordance With Regulatory Circumstances.

An Evaluation of Foreign Clinical Data in the Approval Reviews of Antimicrobial Medicines in Japan: Considering Ethnic and Regional Differences in Data Extrapolations in Accordance With Regulatory Circumstances.

Real-World Outcomes of Patients With Non-Valvular Atrial Fibrillation on Anticoagulants Ineligible for Phase III Trials of Direct Oral Anticoagulants - A Retrospective Cohort Study.

Real-World Outcomes of Patients With Non-Valvular Atrial Fibrillation on Anticoagulants Ineligible for Phase III Trials of Direct Oral Anticoagulants - A Retrospective Cohort Study.

Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data.

Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data.

Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study.

Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study.

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).

Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: A tripartite comparison.

Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: A tripartite comparison.

Comparative examination of levodopa pharmacokinetics during simultaneous administration with lactoferrin in healthy subjects and the relationship between lipids and COMT inhibitory activity in vitro.

Comparative examination of levodopa pharmacokinetics during simultaneous administration with lactoferrin in healthy subjects and the relationship between lipids and COMT inhibitory activity in vitro.

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.

Comparative study on the activities of part-time occupational physicians in Japan between 2008 and 2016: effects of the stress-check program.

Comparative study on the activities of part-time occupational physicians in Japan between 2008 and 2016: effects of the stress-check program.

Biological monitoring of occupational exposure to dichloromethane by means of urinalysis for un-metabolized dichloromethane.

Biological monitoring of occupational exposure to dichloromethane by means of urinalysis for un-metabolized dichloromethane.

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus.

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus.

Real-World Outcomes of Patients With Non-Valvular Atrial Fibrillation on Anticoagulants Ineligible for Phase III Trials of Direct Oral Anticoagulants　- A Retrospective Cohort Study.

Real-World Outcomes of Patients With Non-Valvular Atrial Fibrillation on Anticoagulants Ineligible for Phase III Trials of Direct Oral Anticoagulants　- A Retrospective Cohort Study.